Cargando…

Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis

The pivotal cell involved in the pathogenesis of liver fibrosis, i.e., the activated hepatic stellate cell (HSC), has a wide range of activities during the initiation, progression and even regression of the disease. These HSC-related activities encompass cellular activation, matrix synthesis and deg...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Fransien, Hazelhoff, Christa M., Post, Eduard, Prins, Gerian G. H., Rombouts, Krista, Poelstra, Klaas, Olinga, Peter, Beljaars, Leonie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151042/ https://www.ncbi.nlm.nih.gov/pubmed/32244897 http://dx.doi.org/10.3390/pharmaceutics12030278

Ejemplares similares

Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma
por: van Dijk, Fransien, et al.
Publicado: (2015)

Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury
por: van Beuge, Marike Marjolijn, et al.
Publicado: (2013)

Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632
por: van Beuge, Marike Marjolijn, et al.
Publicado: (2011)

Phosphate Groups in the Lipid A Moiety Determine the Effects of LPS on Hepatic Stellate Cells: A Role for LPS-Dephosphorylating Activity in Liver Fibrosis
por: Schippers, Marlies, et al.
Publicado: (2020)

Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2020)

Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans
por: Beljaars, Leonie, et al.
Publicado: (2014)

Targeting 15d-Prostaglandin J(2) to Hepatic Stellate Cells: Two Options Evaluated
por: Hagens, Werner I., et al.
Publicado: (2007)

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats
por: Klein, Sabine, et al.
Publicado: (2019)

Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice
por: Poosti, Fariba, et al.
Publicado: (2016)

Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo
por: Poosti, Fariba, et al.
Publicado: (2015)

Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis
por: Lachowski, Dariusz, et al.
Publicado: (2019)

Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature
por: Nomden, Mark, et al.
Publicado: (2020)

Explaining the polarized macrophage pool during murine allergic lung inflammation
por: Draijer, Christina, et al.
Publicado: (2022)

Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor
por: Cortes, Ernesto, et al.
Publicado: (2018)

Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
por: Salvati, Anna, et al.
Publicado: (2022)

TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
por: Singh, Harsimran D., et al.
Publicado: (2017)

Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species
por: Dat, Ninh Quoc, et al.
Publicado: (2021)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Versatility of Capsular Flaps in the Salvage of Exposed Breast Implants
por: Brunetti, Beniamino, et al.
Publicado: (2015)

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
por: Pastore, Mirella, et al.
Publicado: (2022)

Shifting Paradigms for Suppressing Fibrosis in Kidney Transplants: Supplementing Perfusion Solutions With Anti-fibrotic Drugs
por: van Leeuwen, L. Leonie, et al.
Publicado: (2022)

The versatility of macrophage heterogeneity in liver fibrosis
por: Gao, Chun-Chen, et al.
Publicado: (2022)

Epigenetics as a versatile regulator of fibrosis
por: Liu, Yangdan, et al.
Publicado: (2023)

Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
por: Michalski, Christoph W., et al.
Publicado: (2008)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Apamin suppresses biliary fibrosis and activation of hepatic stellate cells
por: Kim, Jung-Yeon, et al.
Publicado: (2017)

Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis
por: Cha, Jin Joo, et al.
Publicado: (2020)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity
por: Guo, Hao, et al.
Publicado: (2019)

Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling
por: Sato-Matsubara, Misako, et al.
Publicado: (2017)

Editorial: Organ Fibrosis: Triggers, Pathways, and Cellular Plasticity
por: Mutsaers, Henricus A. M., et al.
Publicado: (2016)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis
por: Kawada, Norifumi
Publicado: (2004)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Neutrophil–Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis
por: Zhou, Zhou, et al.
Publicado: (2018)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n7m7vtcah3ifm44fr9asukk1o2